On October 23, Unilever PLC fell 5.15% in After-Hours Trading, trading at $67.0 per share, with turnover of $2.1677 million.

The main disclosed catalyst was the company’s confirmed agreement to sell first-aid and bandage brand Welly Health to Forward Consumer Partners, with the transaction expected to close by the end of the year and financial terms undisclosed.

The divestment fits Unilever PLC’s broader portfolio-optimization strategy. Earlier in the year, the company reported second-quarter underlying sales growth of 5.8%, turnover of 13.05 billion euros, and raised its full-year underlying sales growth outlook to 4% to 6%, reinforcing investor focus on core-category concentration and operating efficiency. Welly founder Eric Ryan is also set to return after closing as a strategic advisor and board member.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)